A nonbenzodiazepine is a type of prescription sleep medication that works similarly to benzodiazepines (like Valium or Xanax) but has a completely different chemical structure. These drugs are commonly called “Z-drugs” because their generic names all start with the letter Z: zolpidem (Ambien), zaleplon (Sonata), zopiclone (Imovane), and eszopiclone (Lunesta). They are prescribed almost exclusively for insomnia, and they represent a narrower, more targeted approach to helping people fall and stay asleep.
How Z-Drugs Work in the Brain
Both benzodiazepines and nonbenzodiazepines boost the activity of GABA, the brain’s main calming chemical. They do this by latching onto the same receptor, called the GABA-A receptor, and amplifying GABA’s natural sedating effect. The key difference is where on that receptor they bind.
Benzodiazepines are less selective. They attach to multiple subtypes of the GABA-A receptor, which is why they produce a wide range of effects: sedation, anxiety relief, muscle relaxation, and seizure suppression. Nonbenzodiazepines bind more selectively to just one subtype, known as the alpha-1 subunit, which is specifically tied to sedation. This selective binding is the reason Z-drugs can put you to sleep without as many of the other effects (and side effects) that benzodiazepines cause.
The Four Z-Drugs
Each Z-drug has a slightly different profile, largely because of how quickly it’s absorbed and how long it stays active in your body. The main distinguishing factor is elimination half-life, which is the time it takes your body to clear half the drug from your system.
- Zaleplon (Sonata) has the shortest half-life at roughly 1 hour. It reaches peak concentration in your blood within about 45 to 85 minutes. Because it clears so fast, it’s best suited for people who have trouble falling asleep but not staying asleep. It’s also sometimes used for middle-of-the-night awakenings, since it’s unlikely to cause grogginess the next morning.
- Zolpidem (Ambien) has a half-life of 2.5 to 3 hours and peaks in 1 to 2 hours. It comes in both immediate-release and extended-release forms. The extended-release version is designed for people who fall asleep fine but wake up too early. Zolpidem is the most widely prescribed hypnotic in the United States and is also sold under the brand names Edluar, Intermezzo, and ZolpiMist.
- Eszopiclone (Lunesta) has the longest half-life of the group at 6 to 7 hours, peaking within about 1 hour. Its longer duration means it helps with both falling asleep and staying asleep through the night, but it also carries a higher chance of next-morning drowsiness.
- Zopiclone (Imovane) falls in the middle with a half-life of 5 to 6 hours. It is available in many countries but is not FDA-approved in the United States. Eszopiclone is essentially a refined version of zopiclone.
All of these medications should be taken immediately before bed on an empty stomach. Eating a heavy or high-fat meal before taking them slows absorption, which can delay the onset of sleep and reduce how well the drug works.
How They Differ From Benzodiazepines
The most practical difference is scope. Benzodiazepines are prescribed for a wide range of conditions: about 60% of benzodiazepine prescriptions are for anxiety, 29% for sleep, and smaller shares for mood disorders, seizures, and alcohol withdrawal. Nonbenzodiazepines, by contrast, are used almost entirely for sleep. In national survey data from 2013 to 2014, nearly 98% of nonbenzodiazepine prescriptions were for sleep problems.
Because Z-drugs target only the sedation-related part of the GABA-A receptor, they generally produce less muscle relaxation, less anti-anxiety effect, and less of the “heavy” sedated feeling that benzodiazepines can cause. This narrower side effect profile was a major reason they were developed as an alternative for insomnia. That said, they are not risk-free, and they share several important concerns with benzodiazepines, including the potential for dependence and withdrawal.
Side Effects and Safety Risks
Common side effects of Z-drugs include drowsiness the next day, dizziness, headache, and an unpleasant taste in the mouth (particularly with eszopiclone). The risk of next-day impairment depends heavily on which drug you take and its half-life. Zaleplon, with its 1-hour half-life, is least likely to cause morning grogginess. Eszopiclone, at 6 to 7 hours, is most likely.
The more serious concern involves what the FDA calls “complex sleep behaviors.” These are activities people perform while not fully awake, including sleepwalking, sleep-driving, making phone calls, or preparing food with no memory of it the next day. While rare, these episodes have caused serious injuries and, in some cases, deaths. In 2019, the FDA added its strongest possible warning, a Boxed Warning, to the prescribing information for zolpidem, zaleplon, and eszopiclone. The FDA also made it a formal contraindication to prescribe these drugs to anyone who has previously experienced a complex sleep behavior episode while taking them.
Alcohol significantly increases the risk of both next-day drowsiness and complex sleep behaviors. Combining Z-drugs with alcohol or other sedating substances is particularly dangerous.
Dependence and Long-Term Use
Z-drugs were originally marketed as having a lower risk of dependence compared to benzodiazepines, and for short-term use, the risk does appear to be lower. However, long-term use has become common. National survey data show that about 85% of nonbenzodiazepine prescriptions are filled on a medium- or long-term basis. With extended use, tolerance can develop, meaning you need higher doses to get the same effect, and stopping abruptly can trigger rebound insomnia or withdrawal symptoms like anxiety and irritability.
This pattern is one reason that cognitive behavioral therapy for insomnia (CBT-I) is now generally recommended as a first-line treatment before sleep medications. CBT-I addresses the habits and thought patterns that perpetuate insomnia without the risks of medication dependence.
Drug Interactions and Metabolism
All Z-drugs are processed in the liver, primarily by an enzyme called CYP3A4. Any medication that slows down this enzyme can cause Z-drugs to build up to higher-than-expected levels in your blood, intensifying both their sedating effects and their side effects. Common examples include certain antifungal medications, some antibiotics, and grapefruit juice. Conversely, drugs that speed up CYP3A4 activity can make Z-drugs less effective.
Older adults metabolize these drugs more slowly, which is why lower starting doses are typically recommended for people over 65. Women also tend to clear zolpidem more slowly than men, which led the FDA to recommend lower doses for women in 2013 after reports of next-morning impairment.